Visual assessment of coronary artery calcification on low-dose CT scans provides a significant indicator of cardiovascular death, a study found.
Visual assessment of coronary artery calcification on low-dose CT scans provides a significant indicator of cardiovascular death, a study found.
Coronary artery calcification was assessed on ungated low-dose CT scans of the chest in a cohort of 8782 smokers aged 40 to 85. Each participant received a coronary artery calcification score of 0 to 12. The date and cause of death were obtained through the National Death Index.
The rate of cardiovascular deaths increased with an increasing coronary artery score. For patients with a score of zero, the rate was 1.2%. For patients with a score of one to three, the rate was 1.8%; for patients with a score of seven to 12, the rate was 5.3%. A score of at least four was a significant predictor of cardiovascular death, the researchers said. Follow-up ranged from 0.3 months to 91.9 months with a median of 72.3 months (Radiol 2010;257:541-548).
Even after adjusting for sex, age, and pack-years of smoking, the coronary artery calcification score remained significant.Even after adjusting for sex, age, and pack-years of smoking, the coronary artery calcification score remained significant.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.